0.00Open0.00Pre Close0 Volume0 Open Interest4.00Strike Price0.00Turnover0.00%IV37.30%PremiumNov 29, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma12.76Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Recursion Pharmaceuticals Stock Discussion
especially after acquiring Exscientia the competition has turned into synnergy
recent investment from Cathie Wood
ARK investment
This $NVIDIA (NVDA.US)$ portfolio company recently acquired Exacientia UK based company.
Buy for the target of 9
only Pharma company in $NVIDIA (NVDA.US)$ Portfolio using AI for drug discovery
No comment yet